Challenger Ltd (ASX:CGF) (FY 2026) Earnings Call Highlights: Record Annuity Sales and Strategic ...

Negative Points

• Challenger Ltd ( ASX:CGF ) faces a challenging operating environment with tight credit spreads, which has moderated investment yield and required disciplined capital deployment.

• The new reporting framework introduces complexity, with FY27 core EPS guidance of $0.45-$0.49 being lower than the old normalized EPS of $0.681, potentially confusing investors.

• The Fidante-Channel merger is expected to be a drag on core earnings in FY27, with the gain on sale and earn-out payments reported outside core earnings.

• Operating costs of approximately $8 million post-tax are anticipated in FY27 to establish the Calix Re offshore reinsurance platform, impacting near-term earnings.

• The maturity rate is expected to increase to 26% in FY27, driven by large short-term institutional business written previously, which could pressure book growth.

• The company has not provided guidance on investment returns, which are a key component of operating EPS, creating uncertainty for investors.

• The effective tax rate remains slightly above 30% due to nondeductible capital notes, limiting after-tax earnings growth.

• The transition to the new capital standards and reporting framework may lead to short-term volatility in reported metrics, as seen in the 20% decline in the life contracted services margin (partly due to currency).

• The medium-term targets of 8-10% operating EPS growth and 12-14% ROE are aspirational and depend on credit spreads widening and successful execution of growth strategies.

• The company's reliance on partnerships and new product launches carries execution risk, with no guarantee of achieving the targeted $50 billion AUM by 2030.

Q & A Highlights

Q: What assumptions underpin the new 8% to 10% three-to-five-year operating EPS growth target, and how does the ROE expansion from shifting to fixed income factor into this? A: Nick Hamilton (CEO) and Alexandra Bell (CFO) explained that the target is based on FY26 as the baseline year. The growth will be driven by operational leverage as the balance sheet scales, and by a shift towards less capital-intensive fixed income assets, which supports higher returns per unit of equity. They clarified that the new operating ROE target of 12% to 14% is a through-the-cycle range, with the bottom end already above FY26's delivery. The company expects to operate at the top end of its PCA range (1.15x-1.35x) and has not factored in any assumptions about credit spreads widening, which presents potential upside.

Q: How should we interpret the FY27 core EPS guidance of $0.45 to $0.49, and what is the bridge from the FY26 normalized EPS of $0.681? A: Alexandra Bell (CFO) detailed the walk from FY26 normalized EPS to the FY27 core EPS guidance. The FY26 core EPS equivalent is $0.442, which removes normalized accruals for income and capital growth and less predictable returns on non-fixed income assets. The bridge to the FY27 midpoint of $0.47 includes underlying growth from capital deployment, offset by the drag from the Fidante/Channel merger and an approximate $8 million post-tax impact from establishing the Calix Re offshore reinsurance platform. She emphasized this is not a change in earnings power but a clearer economic lens, with an illustrative FY27 normalized EPS of $0.71 under the old framework.

Q: Can you explain the new capital standards' impact on resilience and growth capacity, and what does the revised PCA target range of 1.15x to 1.35x signify? A: Alexandra Bell (CFO) highlighted that under the new APRA standards, the balance sheet is materially more resilient. In an illustrative COVID-like stress, the PCA would fall only 5 points under the new standards versus 25 points under the old regime. This resilience allows the company to lean into crises and capture opportunities when spreads widen. The lower PCA target range is a representation of strength, not deterioration, enabled by the more stable capital position and a more conservative risk appetite. She illustrated that the company could support life book growth of 30% (~$7 billion) with almost no change to asset allocation, or up to 80% growth (~$18 billion) after remixing assets, without needing to raise fresh equity.

Q: What is the outlook for the maturity rate, which is expected to step up to 26% in FY27, and how does this align with the narrative of improving long-duration sales? A: Alexandra Bell (CFO) explained that the higher maturity rate is a mathematical outworking of previously written business, specifically large short-term institutional business that was written earlier in the year and meets ROE targets. Nick Hamilton (CEO) added that the new growth channels, such as the CABN program (with future 5- and 7-year tenors), lifetime business through retirement partnerships, and long-dated reinsurance with Japan, are all consistent with a lower maturity rate going forward. However, they remain opportunistic and will write shorter-duration business if it meets ROE hurdles.

Q: What is the difference between core EPS growth and operating EPS growth, and should we expect core EPS to accelerate into the medium-term target? A: Alexandra Bell (CFO) confirmed that the FY27 core EPS growth of 6% is a strong result and materially up on the prior year's growth. As the asset mix changes and the balance sheet shifts towards fixed income, core earnings are expected to grow as a percentage of total operating profit. This means core EPS, which will be guided annually, should accelerate into the 8% to 10% operating EPS target over the three-to-five-year period.

Q: How much of the $6 billion savings target is assumed to be sold in FY27, and what is the profit signature of new business? A: Nick Hamilton (CEO) stated that new business written in any given year has a relatively small impact on that year's profit because it fits into the broader in-situ book. The FY27 EPS guidance is therefore built up more from the existing book than from new sales, whether through CABN or other channels. The profit signature of new business is a longer-term contributor to earnings.

Q: What is the expected group tax rate going forward, particularly with the expansion of the Bermuda-based Calix Re platform? A: Alexandra Bell (CFO) noted that the effective tax rate has come down closer to 30%, but remains slightly elevated due to the one remaining non-deductible Challenger capital notes. In the near term, the volume of business written through Calix Re is modest relative to the group, so it does not significantly reduce the ETR. She clarified that tax will be paid in the U.S. at 21% out of Calix Re, but the overall group rate should be thought of as just above 30%.

Q: What does the FY27 core EPS of $0.47 translate to for operating EPS, and what are the assumptions for investment returns? A: Alexandra Bell (CFO) stated that the company is deliberately not guiding to investment returns for any single year, as they are less predictable. However, the analyst pack provides target total return ranges for each asset class. The new framework separates predictable core earnings from lumpy investment returns, making the guided items easier to model. The operating EPS will include investment returns, which are expected to contribute positively through the cycle.

Q: What is the timeline to reach the midpoint of the 12% to 14% ROE target, and what are the key levers to reach the top end? A: Alexandra Bell (CFO) indicated these are three-to-five-year targets, dependent on the mix of business written and the types of fixed income assets originated. The two most material levers are the movement of credit spreads and the speed of executing the share buyback. Nick Hamilton (CEO) added that the gain on sale from the Fidante/Channel merger, expected in FY27, will also contribute to the operating ROE.

Q: Can you break down the step-up in the COE margin between the first and second halves, and what is the outlook for the margin?For the complete transcript of the earnings call, please refer to the full earnings call transcript .